ProPhase Labs (PRPH) Announces $6 Million Stock Repurchase Program

Go back to ProPhase Labs (PRPH) Announces $6 Million Stock Repurchase Program

ProPhase Labs Announces $6 Million Stock Repurchase Program

September 8, 2021 8:30 AM UTC

Garden City, NY, Sept. 08, 2021 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a diversified biotech and genomics company, today announced that its Board of Directors has authorized the repurchase of up to $6 million in ProPhase common stock.

The Company has engaged ThinkEquity to facilitate the share repurchase program. Under the new program, the Company may repurchase its common stock from time to time, over the next six months, through open market transactions (based on prevailing market prices), privately negotiated transactions, block trades, or any combination thereof, in accordance with... More